These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 25737009)
1. Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors. Geng CA; Huang XY; Ma YB; Zhang XM; Chen JJ Bioorg Med Chem Lett; 2015 Apr; 25(7):1568-71. PubMed ID: 25737009 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents. Liu S; Wei W; Li Y; Liu X; Cao X; Lei K; Zhou M Eur J Med Chem; 2015 May; 95():473-82. PubMed ID: 25847765 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of hemslecin A derivatives: a new class of hepatitis B virus inhibitors. Guo RH; Geng CA; Huang XY; Ma YB; Zhang Q; Wang LJ; Zhang XM; Zhang RP; Chen JJ Bioorg Med Chem Lett; 2013 Mar; 23(5):1201-5. PubMed ID: 23385212 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure-activity relationships and biological evaluation of caudatin derivatives as novel anti-hepatitis B virus agents. Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Guo RH; Zhang XM; Chen JJ Bioorg Med Chem; 2012 May; 20(9):2877-88. PubMed ID: 22472044 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents. Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Zhang XM; Chen JJ Bioorg Med Chem Lett; 2012 May; 22(10):3473-9. PubMed ID: 22520261 [TBL] [Abstract][Full Text] [Related]
6. Anti-HBV agents. Part 3: preliminary structure-activity relationships of tetra-acylalisol A derivatives as potent hepatitis B virus inhibitors. Zhang Q; Jiang ZY; Luo J; Ma YB; Liu JF; Guo RH; Zhang XM; Zhou J; Niu W; Du FF; Li L; Li C; Chen JJ Bioorg Med Chem Lett; 2009 Dec; 19(23):6659-65. PubMed ID: 19853440 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents. Qiu J; Xu B; Huang Z; Pan W; Cao P; Liu C; Hao X; Song B; Liang G Bioorg Med Chem; 2011 Sep; 19(18):5352-60. PubMed ID: 21872478 [TBL] [Abstract][Full Text] [Related]
8. A new series of HAPs as anti-HBV agents targeting at capsid assembly. Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives. Liu S; Li Y; Wei W; Wang K; Wang L; Wang J Chem Biol Interact; 2016 May; 251():1-9. PubMed ID: 26980103 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-hepatitis B virus activity of a novel class of thiazolylbenzimidazole derivatives. Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W Arch Pharm (Weinheim); 2011 Feb; 344(2):78-83. PubMed ID: 21290423 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and bioevaluation of paeonol derivatives as potential anti-HBV agents. Huang TJ; Chuang H; Liang YC; Lin HH; Horng JC; Kuo YC; Chen CW; Tsai FY; Yen SC; Chou SC; Hsu MH Eur J Med Chem; 2015 Jan; 90():428-35. PubMed ID: 25461891 [TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents. Guo RH; Zhang Q; Ma YB; Luo J; Geng CA; Wang LJ; Zhang XM; Zhou J; Jiang ZY; Chen JJ Eur J Med Chem; 2011 Jan; 46(1):307-19. PubMed ID: 21145140 [TBL] [Abstract][Full Text] [Related]
13. Anti-hepatitis B virus and anti-cancer activities of novel isoflavone analogs. Zhang Y; Zhong H; Lv Z; Zhang M; Zhang T; Li Q; Li K Eur J Med Chem; 2013 Apr; 62():158-67. PubMed ID: 23353737 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiviral activity of new acrylamide derivatives containing 1,2,3-thiadiazole as inhibitors of hepatitis B virus replication. Dong WL; Liu ZX; Liu XH; Li ZM; Zhao WG Eur J Med Chem; 2010 May; 45(5):1919-26. PubMed ID: 20149495 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitors. Jia H; Song Y; Yu J; Zhan P; Rai D; Liang X; Ma C; Liu X Eur J Med Chem; 2017 Aug; 136():144-153. PubMed ID: 28494252 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors. Qiu J; Gong Q; Gao J; Chen W; Zhang Y; Gu X; Tang D Eur J Med Chem; 2018 Jan; 144():424-434. PubMed ID: 29288943 [TBL] [Abstract][Full Text] [Related]
17. Anti-hepatitis B virus active constituents from Swertia chirayita. Zhou NJ; Geng CA; Huang XY; Ma YB; Zhang XM; Wang JL; Chen JJ Fitoterapia; 2015 Jan; 100():27-34. PubMed ID: 25447162 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure-activity relationships and biological evaluation of dehydroandrographolide and andrographolide derivatives as novel anti-hepatitis B virus agents. Chen H; Ma YB; Huang XY; Geng CA; Zhao Y; Wang LJ; Guo RH; Liang WJ; Zhang XM; Chen JJ Bioorg Med Chem Lett; 2014 May; 24(10):2353-9. PubMed ID: 24731274 [TBL] [Abstract][Full Text] [Related]
19. Isolation, synthesis and anti-hepatitis B virus evaluation of p-hydroxyacetophenone derivatives from Artemisia capillaris. Zhao Y; Geng CA; Chen H; Ma YB; Huang XY; Cao TW; He K; Wang H; Zhang XM; Chen JJ Bioorg Med Chem Lett; 2015 Apr; 25(7):1509-14. PubMed ID: 25737008 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of new N(4)-Substituted 2'-deoxy-2'-fluoro-4'-azido cytidine derivatives as potent anti-HBV agents. Lv Z; He W; Tian X; Kang J; Liu Y; Peng Y; Zheng L; Wang Q; Yu W; Chang J Eur J Med Chem; 2015 Aug; 101():103-10. PubMed ID: 26119991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]